Against that background, even with new, lowered regulatory bar for new therapeutics, it seems unlikely that approval would occur after studies of a dozen patients (the size of the study, as listed on clinicaltrials.gov).
On the other hand, because the path to extremism so often involves the renunciation of everything in one's own background, material comfort and a liberal upbringing seem to be no bar to the development of a terrorist.